*Antibody Technology Interest Network Presentation:* *Rapid Discovery of Functional Antibodies for SARS-CoV-2* The COVID-19 pandemic highlights the importance of a flexible and rapid response to real-time development of medical countermeasures for life-threatening viral pathogens. Using human B cells from survivors are a potential source of therapeutic antibodies, Dr. Carnahan will describe the pandemic response platform developed and deployed at the Vanderbilt Vaccine Center that has led to a large panel of anti-viral antibodies directed at SARS-CoV-2, including several antibodies currently in advanced clinical development.
*Monday, October 26, 2020 11:00 a.m.–12:00 p.m. ET *Register here <https://us02web.zoom.us/meeting/register/tZEscOiorTsvHNwYx2ZgZi_I9SH5l_OAD8Fj> Register today to join us for this timely and informative presentation. Speakers: *Robert Carnahan, Ph.D.* <https://www.vumc.org/crowe-lab/person/robert-carnahan-phd> Associate Director, Vanderbilt Vaccine Center Associate Professor, Pediatrics and Radiology and Radiologic Sciences Vanderbilt University Medical Center *David Blum, Ph.D.* <https://www.bmb.uga.edu/directory/people/david-blum> Director, Bioexpression and Fermentation Facility Director, Master of Biomanufacturing and Bioprocessing University of Georgia